Oxford Asset Management LLP Acquires Shares of 31,347 Organigram Holdings Inc. (NASDAQ:OGI)

Oxford Asset Management LLP acquired a new stake in shares of Organigram Holdings Inc. (NASDAQ:OGI) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 31,347 shares of the company’s stock, valued at approximately $50,000.

A number of other institutional investors also recently added to or reduced their stakes in OGI. Arrowstreet Capital Limited Partnership acquired a new stake in Organigram during the fourth quarter valued at approximately $1,153,000. Tidal Investments LLC raised its stake in shares of Organigram by 8.3% in the third quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after acquiring an additional 149,171 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Organigram by 13.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company’s stock valued at $579,000 after acquiring an additional 43,721 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Organigram by 2.4% in the fourth quarter. Renaissance Technologies LLC now owns 914,648 shares of the company’s stock valued at $1,473,000 after acquiring an additional 21,200 shares during the last quarter. Finally, Two Sigma Securities LLC bought a new position in shares of Organigram in the fourth quarter valued at approximately $26,000. 34.63% of the stock is owned by institutional investors and hedge funds.

Organigram Trading Down 3.4 %

NASDAQ:OGI opened at $1.12 on Tuesday. Organigram Holdings Inc. has a 1 year low of $0.85 and a 1 year high of $2.17. The firm has a 50 day moving average of $1.06 and a 200-day moving average of $1.40. The stock has a market capitalization of $141.43 million, a P/E ratio of -2.95 and a beta of 1.10.

Organigram (NASDAQ:OGI) last posted its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative return on equity of 8.59% and a negative net margin of 31.69%. As a group, analysts forecast that Organigram Holdings Inc. will post -0.19 EPS for the current fiscal year.

Organigram Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.